Home|Journals|Articles by Year|Audio Abstracts
 

Review Article



Hyaluronan – A multipotent biomolecule in the field of medicine

Shruti Thomas, Rachana Kundur Rajashekar, Siddhi Sudev, Sugandhi Ganapathi, Thangzuanlian Langel, Suma Sarojini.




Abstract

Hyaluronan, a natural biomolecule, has immense potential in the field of medicine. This glycosaminoglycan present naturally in the human body and seen more in connective tissue, skin, and eyes essentially functions as lubricant and helps strengthen bones. Hyaluronan supplements have been used for a plethora of medical applications including cancer and osteoarthritis therapy, wound healing, and regenerative medicine. The revolutionary discoveries in the field of nanotechnology and biopolymers have indeed paved the way for better and more precise uses of hyaluronan by way of newer designs and composites for improved drug efficacy. At the same time, caution has to be exercised, as few recent studies imply the positive role of low molecular weight hyaluronic acid in the progression of some cancers. The present review elaborates on the range of existing applications across various fields ranging from medical treatment to organ development, and sheds light on the possibilities of maximizing its effectiveness.

Key words: Hyaluronan, cancer, wound healing, nanomaterial, stem cells, osteoarthritis






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.